Receptor profile: MT2 acts as a potent agonist at multiple melanocortin receptors, with primary activity at MC1R and MC4R and additional, weaker engagement of MC3R and MC5R, enabling simultaneous study of peripheral pigmentation and central neuroendocrine effects
There is no specific clinical manifestation of MC, and its diagnosis is mainly based on a complimentary examination, such as endoscopic and histopathological tests
The downside: You might get the placebo
It exists as a research chemical, and it is only available for research purposes
When combined with B12 in the compounded formulation, it reduces the number of separate supplements needed
However, their efficacy must be evaluated beyond weight, by integrating body composition